{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:21:09Z","timestamp":1793798469441,"version":"4.6.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"name":"India for the Basic Scientific Research"},{"DOI":"10.13039\/501100007063","name":"University of Delhi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ejmech.2019.04.038","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T11:17:29Z","timestamp":1556104649000},"page":"2-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer's disease"],"prefix":"10.1016","volume":"175","author":[{"given":"Tarana","family":"Umar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Shalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9175-198X","authenticated-orcid":false,"given":"Md Kausar","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Gusain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasimul","family":"Hoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.04.038_bib1","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA work group* under the auspices of department of health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2019.04.038_bib2","series-title":"The World Alzheimer Report 2018 \u2018The State of the Art of Dementia Research: New Frontiers\u2019","author":"Patterson","year":"2018"},{"key":"10.1016\/j.ejmech.2019.04.038_bib3","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.2174\/138161206778792985","article-title":"Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors","volume":"12","author":"Castro","year":"2006","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.04.038_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0306-4522(89)90399-0","article-title":"Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study","volume":"33","author":"Geula","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2019.04.038_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adhes. Migrat."},{"key":"10.1016\/j.ejmech.2019.04.038_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(03)00502-7","article-title":"Treatment of Alzheimer's disease: current status and new perspectives","volume":"2","author":"Scarpini","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2019.04.038_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4155\/fmc.14.25","article-title":"Polypharmacology: the rise of multitarget drugs over combination therapies","volume":"6","author":"Rosini","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.04.038_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer's disease: strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.04.038_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2019.04.038_bib11","doi-asserted-by":"crossref","first-page":"A23","DOI":"10.1038\/399a023","article-title":"Translating cell biology into therapeutic advances in Alzheimer's disease","volume":"399","author":"Selkoe","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.04.038_bib12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2019.04.038_bib13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00005072-199409000-00003","article-title":"Alzheimer's disease: a central role for amyloid","volume":"53","author":"Selkoe","year":"1994","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejmech.2019.04.038_bib14","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","article-title":"Neurodegeneration induced by beta-amyloid peptides in\u00a0vitro: the role of peptide assembly state","volume":"13","author":"Pike","year":"1993","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2019.04.038_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ajpath.2011.03.021","article-title":"Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid \u03b2 fragment in rats","volume":"179","author":"Zussy","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2019.04.038_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0165-0173(95)00016-X","article-title":"Acetylcholine: a neurotransmitter for learning and memory?","volume":"21","author":"Blokland","year":"1995","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ejmech.2019.04.038_bib17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/cr00081a005","article-title":"Acetylcholinesterase: enzyme structure reaction dynamics and virtual transition states","volume":"87","author":"Quinn","year":"1987","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.04.038_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.pa.34.040194.001433","article-title":"The cholinesterases: from genes to proteins","volume":"34","author":"Taylor","year":"1994","journal-title":"Annu. Rev. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.04.038_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/157015910790909520","article-title":"Update on the pharmacological treatment of Alzheimer's disease","volume":"8","author":"Massoud","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2019.04.038_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00093-4","article-title":"Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer\u0300s disease?","volume":"346","author":"Benzi","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.04.038_bib21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase acceleratyes assembly of amyloid-beta-peptides into Alzheimer\u0300s fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2019.04.038_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1006\/bbrc.1997.6357","article-title":"A\u00a0monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme","volume":"232","author":"Reyes","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2019.04.038_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1034\/j.1600-0404.2000.00308.x","article-title":"Acetylcholinesterase-amyloid-beta-peptide interaction and Wnt signaling involvement in Abeta neurotoxicitity","volume":"102","author":"Inestrosa","year":"2000","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.ejmech.2019.04.038_bib24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuropharm.2010.04.005","article-title":"Oxidative stress in Alzheimer disease: a possibility for prevention","volume":"59","author":"Bonda","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.04.038_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejmech.2016.04.053","article-title":"Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies","volume":"119","author":"Kumar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib26","first-page":"1190","volume":"11","author":"Bolognesi","year":"2016","journal-title":"Multitarget Drug Discovery and Polypharmacology, ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.04.038_bib27","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/med.21434","article-title":"Drugs in clinical trials for Alzheimer's disease: the major trends","volume":"37","author":"Bachurin","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2019.04.038_bib28","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/15680266113139990135","article-title":"The multifactorial nature of Alzheimer's disease for developing potential therapeutics","volume":"13","author":"Carreiras","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/10426500008043650","article-title":"Polycyclic pyridines: synthesis of pyridothienopyrimidines pyridothienotriazines and pyridothienotriazepines","volume":"159","author":"Hussin","year":"2000","journal-title":"Phosphorus Sulfur Silicon Relat. Elements"},{"key":"10.1016\/j.ejmech.2019.04.038_bib30","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/S0960-894X(03)00645-0","article-title":"6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)","volume":"13","author":"itherington","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.04.038_bib31","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0960-894X(03)00134-3","article-title":"5-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)","volume":"13","author":"Witherington","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.04.038_bib32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0960-894X(01)00073-7","article-title":"NO-independent stimulators of soluble guanylate cyclase","volume":"11","author":"Straub","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.04.038_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.saa.2010.10.017","article-title":"Complexation of nitrogen and sulphur donor Schiff's base ligand to Cr(III) and Ni(II) metal ions: synthesis, spectroscopic and antipathogenic studies","volume":"78","author":"Sharma","year":"2011","journal-title":"Spectrochim. Acta"},{"key":"10.1016\/j.ejmech.2019.04.038_bib34","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0960-894X(03)00034-9","article-title":"1H-Pyrazolo [3,4-b]pyridine inhibitors of cyclin-dependent kinases","volume":"13","author":"Misra","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.04.038_bib35","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/S0960-894X(03)00381-0","article-title":"1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases: highly potent 2,6-difluorophenacyl analogues","volume":"13","author":"Misra","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.04.038_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","article-title":"Pharmacological inhibitors of glycogen synthase kinase 3","volume":"25","author":"Meijer","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2019.04.038_bib37","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1021\/jm0401006","article-title":"Antileishmanial pyrazolopyridine derivatives: synthesis and structure-activity relationship analysis","volume":"47","author":"De Mello","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib38","first-page":"297","article-title":"Structural chemistry and thermal properties of some pyrimidine complexes","volume":"14","author":"Masoud","year":"2002","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.saa.2008.09.015","article-title":"Cobalt(II), nickel(II), copper(II), zinc(II) and hafnium(IV) complexes of N\u2032-(furan-3-ylmethylene)-2-(4-methoxyphenylamino)acetohydrazide","volume":"72","author":"Emam","year":"2009","journal-title":"Spectrochim. Acta"},{"key":"10.1016\/j.ejmech.2019.04.038_bib40","first-page":"133","article-title":"Synthesis, characterization, and antiviral activities of pyridopyrazolotriazines, phosphorus sulfur silicon relat","volume":"182","author":"Attaby","year":"2007","journal-title":"Elements"},{"key":"10.1016\/j.ejmech.2019.04.038_bib41","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/10426500500326404","article-title":"Synthesis, reactions, and antiviral activity of 1-(1H-Pyrazolo[3,4-b]pyridin-5-yl)ethanone and Pyrido[2\u2032,3\u2032:3,4]pyrazolo[5,1-c][1,2,4]triazine derivatives","volume":"181","author":"Attaby","year":"2006","journal-title":"Phosphorus Sulfur Silicon Relat. Elements"},{"key":"10.1016\/j.ejmech.2019.04.038_bib42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1515\/HC.2002.8.5.427","article-title":"Synthesis and biological evaluation of 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acids against Vaccinia virus","volume":"8","author":"Azevedo","year":"2002","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.ejmech.2019.04.038_bib43","first-page":"255","article-title":"Novel Tacrine-Hydrxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease","volume":"148","author":"Hiremathad","year":"2018","journal-title":"EJMC"},{"key":"10.1016\/j.ejmech.2019.04.038_bib44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/acschemneuro.8b00069","article-title":"Alzheimer's disease, the \u201cOne-Molecule, one-target\u201d paradigm, and the multitarget directed ligand approach","volume":"9","author":"Jesus","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2019.04.038_bib45","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.4155\/fmc-2016-0103","article-title":"Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy","volume":"8","author":"Santos","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib46","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1471-4159.2008.05396.x","article-title":"Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing","volume":"106","author":"Marcade","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib47","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1039\/C8MD00312B","article-title":"New amyloid beta-disaggregating agents: synthesis, pharmacological evaluation, crystal structure and molecular docking of N-(4-((7-chloroquinolin-4-yl)oxy)-3-ethoxybenzyl)amines","volume":"9","author":"Umar","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2019.04.038_bib48","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1016\/j.bmc.2013.03.052","article-title":"Synthesis and evaluation of 7-chloro-4-(piperazin-1-yl)quinolinesulfonamide as hybrid antiprotozoal agents","volume":"21","author":"Salahuddin","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib49","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1021\/bi0474867","article-title":"A\u03b240-Lactam(D23\/K28) models a conformation highly favorable for nucleation of amyloid","volume":"44","author":"Sciarretta","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2019.04.038_bib50","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archneur.1984.04050190080019","article-title":"Subcortical dementia: review of an emerging concept","volume":"41","author":"Cummings","year":"1984","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejmech.2019.04.038_bib51","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1021\/jm400567s","article-title":"Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease","volume":"56","author":"Lu","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib52","first-page":"48","article-title":"Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe","volume":"52","author":"Ou","year":"2004","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib53","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.tetlet.2004.01.067","article-title":"Synthesis and functionalisation of 1H-pyrazolo[3,4-b]pyridines involving copper and palladium-promoted coupling reactions","volume":"45","author":"Lavecchia","year":"2004","journal-title":"Tetrahrdron letters"},{"key":"10.1016\/j.ejmech.2019.04.038_bib54","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1016\/j.bmc.2013.03.052","article-title":"Synthesis and evaluation of 7-chloro-4-(piperazin-1-yl)quinoline-sulfonamide as hybrid antiprotozoal agents","volume":"21","author":"Salahuddin","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib55","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib56","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/jcc.21478","article-title":"A\u00a0new Lamarckian genetic algorithm for flexible ligand-receptor docking","volume":"31","author":"Fuhrmann","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib57","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2174\/092986607781483831","article-title":"ParDOCK: an all atom energy based Monte Carlo docking protocol for protein-ligand complexes","volume":"14","author":"Gupta","year":"2007","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ejmech.2019.04.038_bib58","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1016\/j.febslet.2005.10.031","article-title":"An all atom energy based computational protocol for predicting binding affinities of protein-ligand complexes","volume":"579","author":"Jain","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2019.04.038_bib59","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1021\/ci200193z","article-title":"AADS-an automated active site identification, docking, and scoring protocol for protein targets based on physicochemical descriptors","volume":"51","author":"Singh","year":"2011","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.04.038_bib60","series-title":"PyMOL Reference Manual","author":"DeLano","year":"2003"},{"key":"10.1016\/j.ejmech.2019.04.038_bib61","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1107\/S0108767383000252","article-title":"An empirical method for correcting diffractometer data for absorption effects","volume":"39","author":"Walker","year":"1983","journal-title":"Acta Crystallogr. A: Found. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.04.038_bib62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C: Struct. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib63","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1107\/S0021889812029111","article-title":"WinGX and ORTEP for windows: an update","volume":"45","author":"Farrugia","year":"2012","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.04.038_bib64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.04.038_bib65","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1016\/j.bmc.2015.08.024","article-title":"Multifunctional novel diallyl disulfide (DADS) derivatives with \u03b2-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease","volume":"23","author":"Manral","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.038_bib66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/1062936X.2018.1423641","article-title":"Multi-targeted directed ligands for Alzheimer's disease: design of novel lead coumarin conjugates","volume":"29","author":"Repsold","year":"2018","journal-title":"SAR QSAR Environ. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419303538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419303538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:52:50Z","timestamp":1759326770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419303538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":66,"alternative-id":["S0223523419303538"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.04.038","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}